Table 3 Comparison of laboratory test results, weight, height, BMI and waist circumference between patients with and without diagnosed metabolic syndrome among women.

From: The impact of lifestyle, measured with the HLPCQ questionnaire on the prevalence of metabolic syndrome in Poland: a multicenter study

Variable

The whole group (N = 672)

Metabolic syndrome (N = 150)

Lack of metabolic syndrome (N = 522)

p

Weight [kg]

70.4 ± 15.3

85.8 ± 16.1

66.0 ± 11.8

 < 0.001†

Hight [cm]

164.1 ± 6.4

163.7 ± 6.4

164.1 ± 6.4

0.543†

BMI

26.1 ± 5.5

31.9 ± 5.4

24.5 ± 4.2

 < 0.001†

BMI ≥ 30

139 (20.6)

90 (64.8)

49 (35.2)

 < 0.001‡

Waist circumference [cm]

84.5 ± 13.1

99.5 ± 10.6

80.2 ± 10.3

 < 0.001†

Abdominal obesity N(%)

247 (36.8)

146 (59.1)

101 (40.9)

 < 0.001‡

SBP [mmHg] M ± SD

126.8 ± 17.0

142.3 ± 15.3

122.3 ± 14.7

 < 0.001†

DBP [mmHg] M ± SD

80.4 ± 9.8

88.1 ± 9.3

78.1 ± 8.7

 < 0.001†

Heart action [beats per minute]M ± SD

75.1 ± 10.7

76.4 ± 11.4

74.7 ± 10.5

0.198†

Total cholesterol [mg/dl] M ± SD

205.0 ± 40.8

224.2 ± 36.2

199.5 ± 40.4

 < 0.001†

LDL [mg/dl] M ± SD

122.7 ± 38.0

143.1 ± 35.3

116.8 ± 36.7

 < 0.001†

HDL [mg/dl] M ± SD

62.9 ± 15.7

55.2 ± 12.7

65.1 ± 15.8

 < 0.001†

Non-HDL [mg/dl]M ± SD

142.5 ± 41.6

169.9 ± 35.4

134.6 ± 39.8

 < 0.001†

Triglycerides [mg/dl] M ± SD

108.0 ± 60.2

140.8 ± 58.9

98.5 ± 57.3

 < 0.001†

Glucose [mg/dl]M ± SD

92.1 ± 16.0

101.9 ± 27.8

89.3 ± 8.5

 < 0.001†

  1. BMI—body mass index, kg—kilograms, p—statistical significance; M—mean; SD—standard deviation; N—number; mmHg—millimetres of mercury; mg/dl—milligrams per decilitre; SBP—Systolic Blood Pressure; DBP—Diastolic Blood Pressure, HR—Heart Rate, LDL—low-density lipoprotein; HDL—high-density lipoprotein †Mann–Whitney U test; ‡Chi-squared test; statistically significant values are in bold with the significance level set at p < 0.05.